SUN PHARMA ADVANCED RESEARCH COMPANY
Smallcap | BSE
Sector
Index
Here's the live share price of Sun Pharma Advanced Research Company along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-5.99₹ -15.00
As on Jul 17, 2026, 04:01 PM IST
Source: Dion Global
Sun Pharma Advanced Research Company Price Performance
Today's LowToday's High
₹227.25₹250.50
₹235.25
52 Weeks' Low52 Weeks' High
₹108.20₹289.00
₹235.25
Open Price
₹250.45
Prev. Close
₹250.25
Volume
2,44,414
Source: Dion Global
Sun Pharma Advanced Research Company Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Sun Pharma Advanced Research Company | -11.09 | -1.73 | 59.06 | 80.34 | 46.03 | 1.60 | -0.80 |
| Suven Life Sciences | -8.82 | 24.49 | 66.72 | 117.01 | 12.93 | 73.05 | 33.29 |
| Vimta Labs | -1.17 | 2.78 | 17.14 | 1.59 | 20.19 | 34.38 | 30.00 |
| Choksi Laboratories | -12.22 | -14.40 | 3.88 | 0.14 | -44.76 | 22.29 | 48.78 |
| Vanta Bioscience | 0 | 6.48 | 38.96 | 17.63 | -12.76 | -18.18 | -29.67 |
Source: Dion Global
Over the last one year, Sun Pharma Advanced Research Company has gained 46.03% compared to peers like Suven Life Sciences (12.93%), Vimta Labs (20.19%), Choksi Laboratories (-44.76%). From a 5 year perspective, Sun Pharma Advanced Research Company has underperformed peers relative to Suven Life Sciences (33.29%) and Vimta Labs (30.00%).
Sun Pharma Advanced Research Company Financials
Source: Dion Global
Sun Pharma Advanced Research Company Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 260.05 | 255.61 |
| 10 | 257.69 | 254.28 |
| 20 | 246.22 | 245.57 |
| 50 | 215.28 | 218.5 |
| 100 | 172.97 | 190.97 |
| 200 | 153.85 | 171.55 |
Source: Dion Global
Sun Pharma Advanced Research Company Share Holding Pattern
In the latest quarter, Sun Pharma Advanced Research Company remained same as its previous close in promoter holding, while DII stake decreased to 0.10%, FII holding rose to 2.48%, and public shareholding moved up to 31.77% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Sun Pharma Advanced Research Company Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 17,67,774 | 0.38 | 25.29 |
Source: Dion Global
* Excluding Index & Arbitrage Funds
Sun Pharma Advanced Research Company Corporate Actions
Date Time | Announcement |
|---|---|
| Jul 17, 2026, 02:28 AM IST IST | Sun Pharma Advanced - Business Responsibility and Sustainability Reporting (BRSR) |
| Jul 17, 2026, 02:24 AM IST IST | Sun Pharma Advanced - Notice Of 21St Annual General Meeting To Be Held On August 10, 2026 Along With The Annual Report For FY |
| Jul 17, 2026, 02:19 AM IST IST | Sun Pharma Advanced - Reg. 34 (1) Annual Report. |
| Jul 13, 2026, 11:17 PM IST IST | Sun Pharma Advanced - Announcement under Regulation 30 (LODR)-Change in Directorate |
| Jul 06, 2026, 05:20 PM IST IST | Sun Pharma Advanced - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
Source: Dion Global
About Sun Pharma Advanced Research Company
Sun Pharma Advanced Research Company Ltd. is a Public Limited Listed company incorporated on 01/03/2006 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L73100GJ2006PLC047837 and registration number is 047837. Currently Company is involved in the business activities of Research and experimental development on natural sciences and engineering. Company's Total Operating Revenue is Rs. 1879.17 Cr. and Equity Capital is Rs. 32.45 Cr. for the Year ended 31/03/2026.
- IndustryMedical Research Services
- AddressPlot No. 5 & 6/1, Savli G.I.D.C. Estate, Savli - Vadodara Highway, Vadodra District Gujarat 391775
- Contact
Source: Dion Global
Management
- Mr. Dilip S ShanghviChairman & Non-Exe.Director
- Dr. T RajamannarNon Executive Director
- Ms. Vidhi ShanghviNon Executive Director
- Mr. Venkateswarlu JastiIndependent Director
- Ms. Bhavna DoshiIndependent Director
- Dr. Ferzaan EngineerIndependent Director
- Dr. Robert J SpiegelIndependent Director
- Mrs. Rekha WarriarIndependent Director
FAQs on Sun Pharma Advanced Research Company Share Price
What is the share price of Sun Pharma Advanced Research Company?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Sun Pharma Advanced Research Company is ₹235.25 as on Jul 17, 2026.
What kind of stock is Sun Pharma Advanced Research Company?
The Sun Pharma Advanced Research Company is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Sun Pharma Advanced Research Company?
The market cap of Sun Pharma Advanced Research Company is ₹7,634.37 Cr as on Jul 17, 2026.
What are today's High and Low prices of Sun Pharma Advanced Research Company?
Today’s highest and lowest price of Sun Pharma Advanced Research Company are ₹250.50 and ₹227.25.
What are the 52 Week High and 52 Week Low of Sun Pharma Advanced Research Company?
The 52-week high/low is the highest and lowest price at which Sun Pharma Advanced Research Company stock has traded in the past 52-week or nearly a year. The 52-week high of Sun Pharma Advanced Research Company is ₹289.00 and 52-week low of Sun Pharma Advanced Research Company is ₹108.20 as on Jul 17, 2026.
How has the Sun Pharma Advanced Research Company performed historically in terms of returns?
The Sun Pharma Advanced Research Company has shown returns of -4.98% over the past day, -0.67% for the past month, 60.78% over 3 months, 47.61% over 1 year, 1.97% across 3 years, and -0.59% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Sun Pharma Advanced Research Company?
P/E ratio of and PB ratio of Sun Pharma Advanced Research Company are 4.92 and 5.70 on Jul 17, 2026. While the company gives a dividend yield of 0.00 per annum.
Source: Dion Global
Sun Pharma Advanced Research Company News
✕